These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7542038)

  • 1. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids.
    Laube B; Langosch D; Betz H; Schmieden V
    Neuroreport; 1995 Apr; 6(6):897-900. PubMed ID: 7542038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
    Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR
    Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.
    Welsh BT; Todorovic J; Kirson D; Allen HM; Bayly MD; Mihic SJ
    Brain Res; 2017 Feb; 1657():148-155. PubMed ID: 27923639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.
    Borghese CM; Blednov YA; Quan Y; Iyer SV; Xiong W; Mihic SJ; Zhang L; Lovinger DM; Trudell JR; Homanics GE; Harris RA
    J Pharmacol Exp Ther; 2012 Feb; 340(2):304-16. PubMed ID: 22037201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
    Schmieden V; Betz H
    Mol Pharmacol; 1995 Nov; 48(5):919-27. PubMed ID: 7476923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol restores the function of "hyperekplexic" mutant glycine receptors in Xenopus oocytes and mice.
    O'Shea SM; Becker L; Weiher H; Betz H; Laube B
    J Neurosci; 2004 Mar; 24(9):2322-7. PubMed ID: 14999083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition.
    Schmieden V; Kuhse J; Betz H
    Mol Pharmacol; 1999 Sep; 56(3):464-72. PubMed ID: 10462533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA.
    De Saint Jan D; David-Watine B; Korn H; Bregestovski P
    J Physiol; 2001 Sep; 535(Pt 3):741-55. PubMed ID: 11559772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of glycine receptor subunit creates beta-alanine receptor responsive to GABA.
    Schmieden V; Kuhse J; Betz H
    Science; 1993 Oct; 262(5131):256-8. PubMed ID: 8211147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia.
    Langosch D; Laube B; Rundström N; Schmieden V; Bormann J; Betz H
    EMBO J; 1994 Sep; 13(18):4223-8. PubMed ID: 7925268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.
    Miller PS; Harvey RJ; Smart TG
    Br J Pharmacol; 2004 Sep; 143(1):19-26. PubMed ID: 15302677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.
    Wang CH; Hernandez CC; Wu J; Zhou N; Hsu HY; Shen ML; Wang YC; Macdonald RL; Wu DC
    J Neurosci; 2018 Mar; 38(11):2818-2831. PubMed ID: 29440552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.
    Laube B; Kuhse J; Betz H
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):215-30. PubMed ID: 10639099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine and beta-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA.
    Horikoshi T; Asanuma A; Yanagisawa K; Anzai K; Goto S
    Brain Res; 1988 Sep; 464(2):97-105. PubMed ID: 2464409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracellular domain of homomeric glycine receptors modulates agonist efficacy.
    Ivica J; Lape R; Jazbec V; Yu J; Zhu H; Gouaux E; Gold MG; Sivilotti LG
    J Biol Chem; 2021; 296():100387. PubMed ID: 33617876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of the glycine receptor activated by agonists differing in efficacy.
    Farley NM; Mihic SJ
    Brain Res; 2015 May; 1606():95-101. PubMed ID: 25721789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive allosteric modulators differentially affect full versus partial agonist activation of the glycine receptor.
    Kirson D; Todorovic J; Mihic SJ
    J Pharmacol Exp Ther; 2012 Jul; 342(1):61-70. PubMed ID: 22473615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations within the agonist-binding site convert the homomeric alpha1 glycine receptor into a Zn2+-activated chloride channel.
    Grudzinska J; Schumann T; Schemm R; Betz H; Laube B
    Channels (Austin); 2008; 2(1):13-8. PubMed ID: 18690053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic determinants of agonist action at the recombinant human glycine receptor.
    Lewis TM; Schofield PR; McClellan AM
    J Physiol; 2003 Jun; 549(Pt 2):361-74. PubMed ID: 12679369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.
    Pless SA; Hanek AP; Price KL; Lynch JW; Lester HA; Dougherty DA; Lummis SC
    Mol Pharmacol; 2011 Apr; 79(4):742-8. PubMed ID: 21266487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.